Trials / Conditions / Rectal Cancer Patients

Rectal Cancer Patients

24 registered clinical trials studyying Rectal Cancer Patients — 17 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Short-Course Radiotherapy, Nal-IRI, Capecitabine, and Camrelizumab for Locally Advanced MSS Rectal Cancer NCT07521605	Guangdong Provincial People's Hospital	Phase 2
Not Yet Recruiting	Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer NCT07314528	St. James's Hospital, Ireland	Phase 2
Not Yet Recruiting	Evaluation of Gynecological and Sexual Sequelae NCT07389863	University Hospital, Rouen	—
Not Yet Recruiting	Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression NCT07176182	Sixth Affiliated Hospital, Sun Yat-sen University	Phase 2
Not Yet Recruiting	Postoperative Outcomes of Single-stapled Anastomosis Combined With Transanal Natural Orifice Specimen Extracti NCT07358247	Istituto Clinico Humanitas	—
Not Yet Recruiting	Radiotherapy Plus CAPOX, and Iparomlimab and Tuvonralimab (QL1706) as Neoadjuvant Therapy for LARC NCT07291401	Zhongnan Hospital	Phase 2
Active Not Recruiting	Optimization and Standardization of Single-Port Robotic Transanal Minimally Invasive Surgery for Rectal Tumor NCT07522294	Jeng-Fu You	N/A
Not Yet Recruiting	Total Neoadjuvant Therapy With PD-1 for Locally Advcancer Rectal Cancer NCT07214142	The First Affiliated Hospital of University of Science and Technology of China	Phase 2
Not Yet Recruiting	Walking and Sitting Difficulties After Rectal Cancer Surgery NCT07035600	Sahlgrenska University Hospital	N/A
Recruiting	SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC NCT07198165	Ruijin Hospital	Phase 2
Recruiting	Selective Total Mesorectal Excision Based on Intra-Operative Frozen Section From Local Excision in Rectal Canc NCT07337811	Sun Yat-sen University	N/A
Not Yet Recruiting	Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 (Neo-REACT): A Multi-cente NCT06850090	Shandong Cancer Hospital and Institute	Phase 3
Recruiting	Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01） NCT06647680	The Affiliated Hospital of Qingdao University	Phase 2
Recruiting	Radiotherapy Plus Iparomlimab and Tuvonralimab (QL1706), Regorafenib, and CAPOX as Neoadjuvant Therapy for pMM NCT06911684	Sun Yat-sen University	Phase 2
Recruiting	Rectal Cancer CTC Trial NCT07194616	University Hospital Ostrava	N/A
Completed	Study of Intramural Spread Pattern in Low Rectal Cancer. NCT07202169	First Affiliated Hospital of Wenzhou Medical University	—
Recruiting	To Evaluate Dose and Safety of NanoEcho Particle-1 Using NanoEcho Imaging Device Examinations of Rectal Lymph NCT06693375	NanoEcho AB	Phase 2
Completed	Single-port Robotic Transanal Total Mesorectal Excision NCT06591572	Daping Hospital and the Research Institute of Surgery of the Third Military Medical University	N/A
Recruiting	Single-port Versus Multi-port Robotic Surgery for Rectal Cancer NCT06824688	Daping Hospital and the Research Institute of Surgery of the Third Military Medical University	N/A
Completed	Impact Of Metformin In Rectal Cancer Patients NCT06728982	Minia University	Phase 2 / Phase 3
Recruiting	The Effect of Multimodal Treatment of Rectal Cancer on Circulating Tumor Cells: A Prospective, Observational S NCT07112937	The Institute of Molecular and Translational Medicine, Czech Republic	—
Unknown	Validation of the French Version of the Low Anterior Resection Syndrome (LARS) Among Rectal Cancer Patients NCT03569488	University Hospital, Caen	—
Completed	Validation of the Moroccan Arabic Version of the Low Anterior Resection Syndrome (LARS) and Wexner Score of Co NCT04128657	Moroccan Society of Surgery	—
Withdrawn	DCE-MRI PET Bevacizumab Study in Rectal Cancer NCT01426074	Abramson Cancer Center at Penn Medicine	Phase 2